PhaseRx, Inc. (OTCMKTS:PZRXQ) Short Interest Down 93.3% in March


Share on StockTwits

PhaseRx, Inc. (OTCMKTS:PZRXQ) saw a significant drop in short interest in March. As of March 31st, there was short interest totalling 100 shares, a drop of 93.3% from the March 15th total of 1,500 shares. Based on an average daily trading volume, of 15,000 shares, the short-interest ratio is currently 0.0 days.

PhaseRx stock remained flat at $$0.03 during midday trading on Tuesday. PhaseRx has a 1-year low of $0.00 and a 1-year high of $0.08. The stock’s fifty day moving average is $0.03.

PhaseRx Company Profile

PhaseRx, Inc, a biopharmaceutical company, engages in developing a portfolio of products for the treatment of inherited enzyme deficiencies in the liver using intracellular enzyme replacement therapy. The company develops its products based on its proprietary Hybrid mRNA technology platform, which allows the synthesis of missing enzyme inside the cell.

Recommended Story: Index Funds

Receive News & Ratings for PhaseRx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PhaseRx and related companies with MarketBeat.com's FREE daily email newsletter.